Joensuu, Heikki, et al. “Outcome of Patients With HER2-Positive Breast Cancer Treated With or Without Adjuvant Trastuzumab in the Finland Capecitabine Trial (FinXX)”. Acta Oncologica, vol. 53, no. 2, Feb. 2014, pp. 186-94, doi:10.3109/0284186X.2013.820840.